Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting. Por Gottlieb, AB, Coates, LC, van Mens, LJJ, Armstrong, AW, Merola, JF

Comparison of different remission and low disease definitions in patients with psoriatic arthritis and evaluation of their prognostic value Por Coates, LC, Gottlieb, AB, Merola, JF, Boone, C, Szumski, A, Chhabra, A

Effect of concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) on the efficacy and safety of ixekizumab in biologic dmard-naive patients with active psoriatic a... Por Coates, LC, Gottlieb, AB, Shuler, CL, Lin, C-Y, Samanta, S, Moriarty, SR, Lee, CH, Mease, PJ

Secukinumab demonstrates high and sustained efficacy in nail psoriasis: Post hoc analysis from phase 3 trials in patients with psoriatic arthritis Por Reich, K, Baraliakos, X, Coates, LC, Elewski, B, Bao, W, Kasparek, T, Gaillez, C, Pournara, E, Aassi, M, Perella, C, Gottlieb, AB

Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study Por Egeberg, A, Kristensen, LE, Thyssen, JP, Gislason, GH, Gottlieb, AB, Coates, LC, Jullien, D, Gisondi, P, Gladman, DD, Skov, L, Mallbris, L

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies Por Alinaghi, F, Calov, M, Kristensen, LE, Gladman, DD, Coates, LC, Jullien, D, Gottlieb, AB, Gisondi, P, Wu, JJ, Thyssen, JP, Egeberg, A

Safety of guselkumab with and without prior TNF-α inhibitor treatment: pooled results across four studies in patients with psoriatic arthritis Por Rahman, P, Boehncke, W-H, Mease, PJ, Gottlieb, AB, McInnes, IB, Shawi, M, Wang, Y, Sheng, S, Kollmeier, AP, Theander, E, Yu, J, Leibowitz, E, Marrache, AM, Coates, LC

Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase 3, randomised, placebo controlled, active... Por Ritchlin, CT, Coates, LC, McInnes, IB, Mease, PJ, Merola, JF, Tanaka, Y, Asahina, A, Gossec, L, Gottlieb, AB, Warren, RB, Ink, B, Bajracharya, R, Shende, V, Coarse, J, Landewé, R

Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL) Por McInnes, IB, Asahina, A, Coates, LC, Landewé, R, Merola, JF, Ritchlin, CT, Tanaka, Y, Gossec, L, Gottlieb, AB, Warren, RB, Ink, B, Assudani, D, Bajracharya, R, Shende, V, Coarse, J, Mease, PJ

Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III... Por Coates, LC, Landewé, R, McInnes, IB, Mease, PJ, Ritchlin, CT, Tanaka, Y, Asahina, A, Behrens, F, Gladman, DD, Gosse, L, Orbai, A-M, Gottlieb, AB, Warren, RB, Ink, B, Bajracharya, R, Shende, V, Coarse, J, Merola, JF

Bimekizumab in patients with active psoriatic arthritis and prior inadequate response or intolerance to tumour necrosis factor inhibitors: a randomised, double-blind, placebo-contr... Por Merola, JF, Landewé, R, McInnes, IB, Mease, PJ, Ritchlin, CT, Tanaka, Y, Asahina, A, Behrens, F, Gladman, DD, Gossec, L, Gottlieb, AB, Thaçi, D, Warren, RB, Ink, B, Assudani, D, Bajracharya, R, Shende, V, Coarse, J, Coates, LC

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Resear... Por Poddubnyy, D, Baraliakos, X, Van den Bosch, F, Braun, J, Coates, LC, Chandran, V, Diekhoff, T, van Gaalen, FA, Gensler, LS, Goel, N, Gottlieb, AB, van der Heijde, D, Helliwell, PS, Hermann, KGA, Jadon, D, Lambert, RG, Maksymowych, WP, Mease, P, Nash, P, Proft, F, Protopopov, M, Sieper, J, Torgutalp, M, Gladman, DD